12:00 AM
 | 
Dec 15, 2008
 |  BioCentury  |  Regulation

Risk by endpoint

Risk by endpoint

In a meta-analysis, patients receiving long-acting beta agonists or combination drugs containing LABAs had a higher rate of asthma-related...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >